Weight-Loss Drugs Offer Hope for Kidney Health
Weight-loss drugs, specifically glucagon-like peptide-1 (GLP-1) receptor agonists, have shown promise in reducing the risk of kidney-related issues. A comprehensive analysis of these drugs suggests they can decrease the risk of kidney failure and related complications by a fifth. The study, published in The Lancet Diabetes & Endocrinology, highlights the potential benefits of these drugs…